Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early tacrolimus-to-sirolimus conversion versus tacrolimus maintenance after kidney transplantation
ChiCTR-TRC-12002999Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Aug 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sirolimus and tacrolimus in kidney transplant (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Graft glomerular filtration rate. Started Aug 2012; status: completed.
02
Drugs
sirolimustacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on ChiCTR-TRC-12002999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002999.